Cliff Asness's ROIV Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 70,371 shares of Roivant Sciences Ltd. (ROIV) worth $1.06 M, representing 0.00% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ROIV, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 214,884 shares. Largest reduction occurred in Q2 2024, reducing 96,894 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Roivant Sciences (ROIV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Roivant Sciences (ROIV) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2023 | +107,120 | New Buy | 107,120 | $10.08 |
| Q3 2023 | +7,489 | Add 6.99% | 114,609 | $11.68 |
| Q4 2023 | -27,665 | Reduce 24.14% | 86,944 | $11.20 |
| Q1 2024 | +214,884 | Add 247.15% | 301,828 | $10.43 |
| Q2 2024 | -96,894 | Reduce 32.10% | 204,934 | $10.57 |
| Q3 2024 | -73,512 | Reduce 35.87% | 131,422 | $11.51 |
| Q4 2024 | -131,422 | Sold Out | 131,422 | $0.00 |
| Q3 2025 | +70,371 | New Buy | 70,371 | $15.05 |
Cliff Asness's Roivant Sciences Investment FAQs
Cliff Asness first purchased Roivant Sciences Ltd. (ROIV) in Q2 2023, acquiring 107,120 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Roivant Sciences Ltd. (ROIV) for 10 quarters since Q2 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to Roivant Sciences Ltd. (ROIV) was in Q1 2024, adding 301,828 shares worth $3.15 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 70,371 shares of Roivant Sciences Ltd. (ROIV), valued at approximately $1.06 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Roivant Sciences Ltd. (ROIV) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in Roivant Sciences Ltd. (ROIV) was 301,828 shares, as reported at the end of Q1 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.